oxidopamine has been researched along with pyridine-2-carboxaldehyde in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arsikin, K; Harhaji-Trajkovic, L; Janjetovic, K; Kostic-Rajacic, S; Misirkic-Marjanovic, M; Schrattenholz, A; Soskic, V; Tovilovic, G; Trajkovic, V; Vucicevic, L; Zogovic, N | 1 |
1 other study(ies) available for oxidopamine and pyridine-2-carboxaldehyde
Article | Year |
---|---|
Arylpiperazine-mediated activation of Akt protects SH-SY5Y neuroblastoma cells from 6-hydroxydopamine-induced apoptotic and autophagic death.
Topics: Adenine; Adrenergic Agents; Analysis of Variance; Apoptosis; Autophagy; Cell Survival; Cytoplasm; Dose-Response Relationship, Drug; Drug Interactions; Humans; Macrolides; Neuroblastoma; Neuroprotective Agents; Oxidopamine; Piperazines; Proto-Oncogene Proteins c-akt; Pyridines; RNA, Small Interfering; Signal Transduction; Superoxides; Time Factors | 2013 |